Literature DB >> 22471727

Unrepaired tetralogy of fallot in an 85-year-old man.

Riccardo Gorla1, Andrea Macchi, Irene Franzoni, Isabella Rosa, Fabio Buzzetti, Anna G Pavon, Alberto Margonato.   

Abstract

Tetralogy of Fallot is the most common cyanotic congenital heart defect and accounts for about 5% of all congenital cardiopathies. The definitive treatment modality for tetralogy of Fallot is reparative surgery, which is recommended to be performed by the time of diagnosis. Without surgical repair, most patients would die during their childhood. In the past, survival data indicated that 66% of persons with tetralogy of Fallot not surgically treated lived until the age of 1, 49% lived until the age of 3, and 24% lived until the age of 10. We now present a rare case of a man with unrepaired tetralogy of Fallot who survived until the age of 85. He presented to our emergency room for dyspnea and palpitations due to a new-onset high-frequency atrial fibrillation and acute heart failure; transthoracic echocardiography showed the presence of tetralogy of Fallot. By consulting the scientific literature, we can say that this is the second patient who survived more than 80 years without surgical intervention.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22471727     DOI: 10.1111/j.1747-0803.2012.00642.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  3 in total

1.  An extraordinary survival at the age of 67 years in an unoperated case tetralogy of Fallot presenting as systemic hypertension despite RV dysfunction.

Authors:  Sadashivappa Surhonne Prakash; Rajni Sharma; Navin Agrawal; Somanna Shankar
Journal:  BMJ Case Rep       Date:  2014-01-28

2.  Tetralogy of fallot: a surgical perspective.

Authors:  Tom R Karl
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-08-03

3.  'Superimposed miracles': an extremely rare case of a septuagenarian with an unrepaired tetralogy of Fallot: a case report.

Authors:  Makiko Suzuki; Kensuke Matsumoto; Yu Izawa; Ken-Ichi Hirata
Journal:  Eur Heart J Case Rep       Date:  2021-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.